SpringWorks Therapeutics Inc
NASDAQ:SWTX

Watchlist Manager
SpringWorks Therapeutics Inc Logo
SpringWorks Therapeutics Inc
NASDAQ:SWTX
Watchlist
Price: 46.99 USD 0.02% Market Closed
Market Cap: 3.5B USD

Wall Street
Price Targets

SWTX Price Targets Summary
SpringWorks Therapeutics Inc

There are no price targets for SWTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
SpringWorks Therapeutics Inc Competitors:
Price Targets
XNCR
Xencor Inc
108% Upside
ORY
Oryzon Genomics SA
129% Upside
ALXO
ALX Oncology Holdings Inc
113% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
13% Upside
CRBU
Caribou Biosciences Inc
618% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
8% Upside
ABBV
Abbvie Inc
14% Upside
ABNX
Abionyx Pharma SA
198% Upside

Revenue
Forecast

Revenue Estimate
SpringWorks Therapeutics Inc

The compound annual growth rate of SpringWorks Therapeutics Inc's revenue for the next 3 years is 61%.

N/A
Past Growth
61%
Estimated Growth
Estimates Accuracy
95%
Average Beat

Operating Income
Forecast

Operating Income Estimate
SpringWorks Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
SpringWorks Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SWTX's stock price target?
Not Available

SWTX doesn't have any price targets made by Wall Street professionals.

What is SpringWorks Therapeutics Inc's Revenue forecast?
Projected CAGR
61%

The compound annual growth rate of SpringWorks Therapeutics Inc's revenue for the next 3 years is 61%.

Back to Top